Procoagulant factors in patients with cancer

Hematology

Volumn 12, Issue 6, 2007, Pages 555-559

  Molnar, Soledad ^a   Guglielmone, Hugo ^a   Lavarda, Marcelo ^a   Rizzi, Maria Laura ^a   Jarchum, Gustavo ^a  

^a Division of Hematology and Oncology   (Argentina)

Author keywords

Cancer; Cancer procoagulant; Thrombosis; Tissue factor

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CANCER PROCOAGULANT; PROCOAGULANT; THROMBOPLASTIN; TUMOR MARKER;

ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BREAST CANCER; CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; THROMBOSIS; TUMOR LOCALIZATION; UROGENITAL TRACT CANCER;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYSTEINE ENDOPEPTIDASES; DIGESTIVE SYSTEM NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASMS; PREDICTIVE VALUE OF TESTS; THROMBOPLASTIN; THROMBOSIS; UROGENITAL NEOPLASMS;

EID: 35748932051     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330701521416     Document Type: Article

References (19)

1. Donati, MB (1995) Cancer and thrombosis from phlegmasia alba dolens to transgenic mice. Thromb Haemost, 74, pp. 278-281.
2. Prandoni, P., Falanga, A. and Piccioli, A. (2005) Cancer and venous thromboembolism. Lancet Oncol, 6, pp. 401-410.
3. Sorensen, H., Steffensen, F., Olsen, J. and Nielsen, G. (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or embolism pulmonary. N Engl J Med, 338, pp. 1169-1173.
4. Hillen, HF (2000) Thrombosis in cancer patients. Ann Oncol, 11, pp. 273-276.
5. Rickles, F., Levine, M. and Edwards, R. (1992) Haemostatic alterations in cancer patients. Cancer Metastsis Rev, 11, pp. 208-213.
6. Donati, MB and Falanga, A. (2001) Pathogenetic mechanism of thrombosis in malignancy. Acta Haematol, 106, pp. 18-24.
7. Falanga, A. and Rickles, F. (1999) Pathophysiology of the thrombofilic state in cancer patients. Semin Thromb Haemost, 25, pp. 173-182.
8. Falanga, A. (2001) Tumor cells prothrombotic properties. Haemostasis, 31, pp. 1-4.
9. Eilestsen, K. and Osterud, B. (2004) Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis, 15, pp. 521-538.
10. Rak, J. (2004) Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost, 2, pp. 2065-2067.
11. Gale, A. and Gordon, S. (2001) Update on tumor cell procoagulant factors. Acta Haematol, 106, pp. 25-32.
12. Gordon, S. and Cross, B. (1994) An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new marker. Cancer Res, 50, pp. 6229-6234.
13. Mielicki, W. and Tenderenda, M. (1999) Activation of blood coagulation and the activity of cancer procoagulant breast cancer patients. Cancer Lett, 146, pp. 61-66.
14. Zuchella, M., Pacchiarini, L., Tacconi, F., Saporiti, A. and Griganani, G. (1993) Different expression of procoagulant activity in human cancer cells cultured in vitro or in cells isolated from human tumor tissues. Thromb Haemost, 69, pp. 335-338.
15. Gordon, S. and Benson, B. (1989) Analysis of serum cancer procoagulant activity and its possible use as a tumor marker. Thromb Res, 56, pp. 431-440.
16. Golino, P. (2002) The inhibition of tissue factor: Factor VII pathway. Thromb Res, 95, pp. 257-265.
17. Gianni, M., Norio, P. and Tenao, M. (1995) Effects of dexamethasone on proinflammatory cytokine expression, cell growth and maturation during granulocytic differention of APL cells. Eur Cytokine Network, 6, pp. 157-165.
18. Colucci, M., Delaini, F., Vitti, G De Bellis, Locat, D., Poggi, A. and Donato, MB (1993) Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency. Biochem Pharmacol, 32, pp. 1689-1691.
19. Hau, C., Simrit, P. and Jun, W. (2003) Pathogenesis of increased risk of thrombosis in cancer. Semin Thromb Haemost, 29, pp. 283-290.